MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)
$1.21 -0.02 (-1.626%)
Analysed MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) News Sources
Milestone Pharmaceuticals shares plunge after CARDAMYST revenue misses expectations (MIST)
13-05-2026
advfn.com
Milestone Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript
13-05-2026
yahoo.com
Milestone Pharmaceuticals Q1 Earnings Call Highlights
13-05-2026
marketbeat.com
Why Milestone Pharmaceuticals Stock Wilted on Wednesday
13-05-2026
fool.com
Milestone Pharmaceuticals Inc (MIST) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ...
13-05-2026
yahoo.com
Milestone Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
14-05-2026
moby.co
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
14-05-2026
yahoo.com
Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Path To Profitability
15-05-2026
yahoo.com
Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer
21-05-2026
yahoo.com
Milestone (MIST) Q1 2026 Earnings Transcript
01-06-2026
fool.com
What is the current price of MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)?
The current price of MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) is $1.21.
MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) absolute price change since previous trading day?
The absolute price change of MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) since the previous trading day is $-0.02.
MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) percentage price change since previous trading day?
The percentage price change of MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) since the previous trading day is -1.626%.
What is the most recent average sentiment score for MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)?
The most recent average sentiment score for MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)?
The most recent sentiment for MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) is .
SEC-8K** Filing Available For MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.